GGrantIndex
Sort

166,118 grants matching stem cells

The Molecular Basis of Cell Function

$784,410
Matthew D. Welch · University Of California Berkeley · T32 · FY2017 · GM

Post-transcriptional modification in esophageal basal cells.

$784,280
Jianwen Que · Columbia University Health Sciences · R01 · FY2025 · DK

Targeting the PHD/HIF Pathway to Mitigate Radiation Induced Gl Toxicity

$784,272
Amato J. Giaccia · Stanford University · P01 · FY2013 · CA

Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism

$784,231
Alysson R. Muotri · University Of California, San Diego · R01 · FY2024 · MH

Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality

$784,196
Mohamed Sorror · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA

Core Support for Vision Research

$784,179
Michael Ellis Goldberg · Columbia University Health Sciences · P30 · FY2011 · EY

Mechanisms underlying establishment of regeneration competence

$784,151
Erin Davies · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Impaired activity-dependent protein synthesis in dendrites and pathophysiology in tauopathy

$784,070
Tara Tracy · Buck Institute For Research On Aging · R01 · FY2023 · AG

Development of TGF-beta antagonists for cancer therapy

$784,065
Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Protective genetic factors of Alzheimer disease in PSEN1 Mutation Carriers in Puerto Rico

$784,029
Joseph Hyungwoo Lee · Columbia University Health Sciences · R01 · FY2019 · AG

Cognitive Computing of Alzheimer's Disease Genes and Risk

$783,998
Olivier Lichtarge · Baylor College Of Medicine · U01 · FY2025 · AG

Robust allograft tolerance in non-human primates

$783,995
Megan Sykes · Columbia University Health Sciences · R01 · FY2015 · OD

Developing novel therapies to improve blood stem cell transplantation outcomes

$783,992
Ramiro Garzon · Ohio State University · R01 · FY2022 · HL

Administrative Core COBRE Phase II Stem Cells and Aging

$783,975
Peter J Quesenberry · Rhode Island Hospital · P20 · FY2017 · GM

Development and regulation of stem cell lineages in skin

$783,873
Isaac Brownell · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Cancer and Leukemia Group B - Leukemia Correlative Sciences

$783,858
Guido Marcucci · Ohio State University · U10 · FY2011 · CA

Enhancer RNAs in brain gene regulation and Alzheimer's disease

$783,820
Wenbo Li · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · AG

Generation of Cre/lox rats

$783,752
Qilong Ying · University Of Southern California · R24 · FY2017 · OD

Epigenetic Regulation of Hematopoietic Stem Cells

$783,739
Keji Zhao · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

The role of N6-methyladenosine modified RNA in Alzheimer's disease

$783,699
Benjamin L Wolozin · Boston University Medical Campus · R01 · FY2024 · AG

MMRRC INFORMATICS, COORDINATION, AND SERVICE CENTER AT UC DAVIS

$783,594
Eric Kenneth Engelhard · University Of California At Davis · U42 · FY2011 · RR

The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts

$783,583
Sanjay Misra · Mayo Clinic Rochester · R01 · FY2022 · HL

Hydrogel-enabled self-assembled human brain organoids for neurotoxicity applications

$783,533
Connie S Lebakken · Stem Pharm, Inc. · R44 · FY2022 · ES

Engineered Stem Cells for Cardiac Repair

$783,516
Michael Regnier · University Of Washington · R01 · FY2025 · HL

Cell-type-specific NRXN1alpha alternative splicing changes in psychiatric disease

$783,464
Gang Fang · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · MH